Nephrology and Urology Devices Market Expected to Reach $47.8 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Nephrology and Urology Devices Market," The nephrology and urology devices market size was valued at $31.3 billion in 2022, and is estimated to reach $47.8 billion by 2032, growing at a CAGR of 4.3% from 2023 to 2032. The increase in the prevalence of kidney diseases, urinary tract infections, & urological disorders is one of the major nephrology and urology devices market trends that propels the market growth. For instance, according to the American Cancer Society in 2023, about 82,290 new cases of bladder cancer were reported in the U.S. (about 62,420 in men and 19,870 in women). In addition, growth in preference for minimally invasive procedures further raises the demand for urological and nephrological devices which drive nephrology and urology devices market growth. 

Further, as people age, they become more vulnerable to kidney and urological conditions. The natural aging process led to structural & functional changes in the urinary system and kidneys. For instance, the kidneys tend to filter blood less efficiently and the bladder may lose some of its elasticity. These age-related changes can result in an increased risk of urinary tract infections, kidney stones, urinary incontinence, and other urological problems. Thus, the rise in the geriatric population suffering from urological diseases propels the growth during the nephrology and urology devices market forecast.  

Moreover, growth in awareness about kidney and urological disorders along with initiatives for early diagnosis & preventive care, encourages patients to seek medical attention and drives demand for diagnostic and monitoring devices such as urology devices, which drive growth during nephrology and urology devices market analysis. For instance, the U.S. Department of Health and Human Services has launched the Advancing American Kidney Health initiative, which aims to improve kidney disease prevention and care in the U.S.

The initiative includes scaling programs nationwide to optimize screening for kidney diseases, educating patients on care options with coordinated care networks & other tools, supporting ground-breaking research to inform the next generation of targeted therapies, creating new payment models & financial incentives to encourage utilization of home dialysis and increase access to kidney transplants, thereby encouraging the acceleration of innovation in kidney care and drive the growth of nephrology and urology devices market size. 

However, the high costs of devices may limit access to these services for some patients, especially in regions with limited healthcare resources or for individuals without adequate insurance coverage which hamper nephrology devices market growth. Moreover, the rise in technological advancements in devices and the high growth rate exhibited by developing economies are expected to present a lucrative nephrology and urology devices market opportunity during the forecast period.  

The nephrology and urology devices market is segmented into product, application, end-user, and region. By product, the market is segregated into instruments and consumables & accessories. The instruments segment is further categorized into dialysis devices, endoscopes, laser & lithotripsy devices, endovision & imaging systems, and others. The dialysis device segment is further bifurcated into hemodialysis devices and peritoneal dialysis devices. Endoscopes are classified into cytoscopes, ureteroscopes, and others.

The consumables & accessories segment is further categorized into dialysis consumables, catheters & guidewires, stents, biopsy devices, and others. On the basis of application, the market is categorized into kidney diseases, urological cancer & BPH, and others. As per end user, it is classified into hospitals, dialysis centers, and others. 

By product, the consumables and accessories segment accounted for the largest nephrology and urology devices market share in 2022 and is also expected to register the highest CAGR during the forecast period. This is attributed to the ongoing advancements in materials and design of consumables & accessories have enhanced their performance and patient safety, further driving their segment dominance and further drive growth of the nephrology devices market. 

By application, the kidney diseases segment accounted for the largest nephrology and urology devices market share in 2022. This is attributed to a rise in the number of people suffering from chronic kidney diseases (CKD) and kidney diseases. However, the urological cancer and BPH segment is expected to register the highest CAGR during the forecast period. This is attributed to the surge in the prevalence of urological cancer & BPH, technological advancements in devices, and the growing aging population suffering from urological conditions. 

On the basis of end-users, the hospitals segment accounted for the largest market share in 2022. This is attributed to the hospitals are central hubs for comprehensive healthcare delivery and are equipped with a range of specialized departments and medical professionals, making them essential for addressing complex and diverse needs in nephrology and urology. In addition, comprehensive and specialized care offered within hospital settings, their investment capacity in advanced medical equipment, the ability to handle emergencies, the presence of multidisciplinary healthcare teams, and the growing preference for centralized healthcare delivery further drive the segment growth. 

However, the dialysis centers segment is expected to register the highest CAGR during the forecast period, owing to the fact that as the dialysis centers offer specialized care & medical expertise in managing kidney-related conditions, patients prefer these centers for the convenience of receiving treatment from trained professionals in a clinical setting. 

Region-wise, North America dominated the nephrology and urology devices industry, owing to well-established healthcare infrastructure, a rise in the prevalence of kidney and urological disorders, significant healthcare expenditure, advanced technology adoption, and a rise in the number of product approvals. For instance, in February 2022, Medtronic plc, a global leader in healthcare technology, announced that it has received approval from the U.S. Food and Drug Administration (FDA) for InterStim X, the next generation of the InterStim portfolio's recharge-free device and its available immediately.  

However, Asia-Pacific is anticipated to witness notable growth owing to an increase in the incidence of kidney and urological disorders. In addition, growth in awareness about kidney and urological disorders, along with initiatives for early diagnosis & preventive care, encourages patients to seek medical attention and drives demand for diagnostic and monitoring devices. 

Key Findings of the Study 

• By product, the consumables and accessories segment was the largest contributor to the nephrology and urology devices industry in 2022. 
•  On the basis of application, the kidney diseases segment was the largest contributor to the market in 2022. However, the urological cancer & BPH segment is anticipated to grow at the highest CAGR during the forecast period. 
• Depending on the end user, the hospital segment was the largest contributor to the market in 2022. However, the dialysis centers segment is anticipated to grow at the highest CAGR during the forecast period. 
• Region-wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.